INTRAGLY RESPULE
MRP: 7,990
Packaging: 4x5x2ml
Pack Type: respules
Composition:
Glycopyrronium Inhalation Solution 25 mcg
Indication:
Chronic Obstructive Pulmonary Disease (COPD), including Chronic Bronchitis and/or Emphysema
Description:
Glycopyrronium 25 mcg Inhalation Solution** is a long-acting muscarinic antagonist (LAMA) used in the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing airway muscles and preventing bronchospasm, thereby improving lung function and breathing capacity.
This formulation is not intended for acute bronchospasm relief but for long-term, once-daily maintenance therapy. It is typically administered via a nebulizer or inhalation device.
Tags:
- Provides 24-hour bronchodilation
- Improves lung function and breathing ease
- Reduces exacerbations and hospitalization risk
- Once-daily dosing improves patient adherence
- Minimizes need for rescue medications
Usage Information
Dosage
Recommended dose: 25 mcg once daily by inhalation Use with a standard nebulizer under healthcare guidance Do not exceed recommended dosage Ensure proper cleaning of inhalation device Always use as directed by your healthcare provider.
Side Effects
Common: Dry mouth Sore throat Headache Constipation Cough or throat irritation Serious (Rare): Urinary retention Eye pain or blurred vision (if solution contacts eyes)
Contraindications
Hypersensitivity to glycopyrronium or components Severe renal impairment (dose adjustment may be required) Narrow-angle glaucoma Urinary retention or bladder obstruction Not for rescue therapy in acute bronchospasm
Availability
Glycopyrronium inhalation 25 mcg COPD maintenance inhalation LAMA for chronic bronchitis Long-acting bronchodilator solution Glycopyrronium nebulizer treatment Inhaled anticholinergic for COPD